不孕女性严重孕产妇并发症风险升高:美国保险索赔数据分析
这项基于美国保险索赔数据库的回顾性队列分析纳入19,658例不孕女性和525,695例有生育力女性,比较单胎分娩后6周内严重孕产妇并发症指标。不孕女性任何严重并发症指标风险显著升高(aOR 1.22,95%CI 1.14-1.31,P<.01),且多个具体指标风险亦显著升高。
要点
- 不孕女性任何严重孕产妇并发症指标风险显著高于有生育力女性(aOR 1.22)。
- 接受生育治疗者严重并发症发生率为7.0%,有生育力女性为4.3%。
- 不孕女性多个具体严重并发症指标风险显著升高,包括输血和血栓栓塞等。
核心结论
- 不孕女性及接受生育治疗女性相比有生育力女性,多种严重孕产妇并发症指标风险显著升高。
- 有生育力黑人女性相比有生育力白人女性严重并发症风险显著升高,但不孕黑人女性与不孕白人女性风险相似。
研究设计与样本
- 回顾性队列分析,使用Optum去标识化Clinformatics Data Mart数据库2003至2015年数据。
- 不孕组19,658例,有生育力组525,695例,均仅纳入随访期间单胎妊娠并分娩的女性。
- 主要结局为CDC定义的严重孕产妇并发症指标,通过ICD-10和CPT编码在每次分娩后6周内识别。
- 结果调整了母亲年龄、种族、教育、未产、吸烟、肥胖、分娩方式、早产、产前检查次数和分娩年份。
主要发现
- 任何严重孕产妇并发症指标总体发生率:接受生育治疗者7.0%,接受不孕诊断者6.4%,接受生育力测试者5.5%,有生育力女性4.3%。
- 不孕女性任何严重并发症指标风险显著升高(aOR 1.22,95%CI 1.14-1.31,P<.01)。
- 具体指标风险显著升高:弥散性血管内凝血(aOR 1.48,95%CI 1.26-1.73,P<.01)、子痫(aOR 1.37,95%CI 1.05-1.79,P<.01)、手术或操作中心力衰竭(aOR 1.54,95%CI 1.21-1.97,P<.01)、胸腹盆腔内脏损伤(aOR 1.59,95%CI 1.12-2.26,P<.01)、颅内损伤(aOR 1.77,95%CI 1.20-2.61,P<.01)、肺水肿(aOR 2.18,95%CI 1.54-3.10,P<.01)、血栓栓塞(aOR 1.58,95%CI 1.14-2.17,P<.01)、输血(aOR 1.50,95%CI 1.30-1.72,P<.01)。
- 有生育力女性相比不孕女性未面临任何孕产妇并发症指标的显著更高风险。
- 按母亲种族/民族亚组分析,有生育力黑人女性相比有生育力白人女性严重并发症可能性显著更高;多变量调整后不孕黑人女性与不孕白人女性无差异。
临床怎么用
- 对不孕女性及接受生育治疗者,产科管理时应提高对严重孕产妇并发症的警觉。
- 关注不孕女性围产期弥散性血管内凝血、子痫、心力衰竭、肺水肿、血栓栓塞及输血等风险。
- 不孕黑人女性与不孕白人女性严重并发症风险相似,提示不孕状态可能改变种族相关风险差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe maternal morbidity continues to be an issue of national and global concern and is increasing in incidence. The incidence of infertility is also on the rise, and infertile women experience a higher risk of incident chronic medical disease and cancer, suggesting that fertility may serve as a window to a woman's overall health. OBJECTIVE: To investigate the risk of severe maternal morbidity by maternal fertility status. MATERIALS AND METHODS: This was a retrospective cohort analysis using Optum's de-identifed Clinformatics Data Mart Database between 2003 and 2015. Infertile women stratified by infertility diagnosis, testing, or treatment were compared to fertile women seeking routine gynecologic care. In both groups, only women who underwent pregnancy and delivery of a singleton during the follow-up period were included. Main outcomes were severe maternal morbidity indicators, defined by the Centers for Disease Control and Prevention and identified by International Classification of Diseases 10th Revision and Common Procedural Technology codes within 6 weeks of each delivery. Results were adjusted for maternal age, race, education, nulliparity, smoking, obesity, delivery mode, preterm birth, number of prenatal visits, and year of delivery. RESULTS: A total of 19,658 women comprised the infertile group and 525,695 women comprised the fertile group. The overall incidence of any severe maternal morbidity indicator was 7.0% among women receiving fertility treatment, 6.4% among women receiving a fertility diagnosis, 5.5% among women receiving fertility testing, and 4.3% among fertile women. Overall, infertile women had a significantly higher risk of developing any severe maternal morbidity indicator (adjusted odds ratio, 1.22; confidence interval, 1.14-1.31, P < .01) as well as a significantly higher risk of disseminated intravascular coagulation (adjusted odds ratio, 1.48; confidence interval, 1.26-1.73, P < .01), eclampsia (adjusted odds ratio, 1.37; confidence interval, 1.05-1.79, P < .01), heart failure during procedure or surgery (adjusted odds ratio, 1.54; confidence interval, 1.21-1.97, P < .01), internal injuries of the thorax, abdomen, or pelvis (adjusted odds ratio, 1.59; confidence interval, 1.12-2.26, P < .01), intracranial injuries (adjusted odds ratio, 1.77; confidence interval, 1.20-2.61, P < .01), pulmonary edema (adjusted odds ratio, 2.18; confidence interval, 1.54-3.10, P < .01), thrombotic embolism (adjusted odds ratio, 1.58; confidence interval, 1.14-2.17, P < .01), and blood transfusion (adjusted odds ratio, 1.50; confidence interval, 1.30-1.72, P < .01) compared to fertile women. Fertile women did not face a significantly higher risk of any maternal morbidity indicator compared to infertile women. In subgroup analysis by maternal race/ethnicity, the likelihood of severe morbidity was significantly higher among fertile black women compared to fertile white women. There was no difference between infertile black women and infertile white women after multivariable adjustment. CONCLUSION: Using an insurance claims database, we report that women diagnosed with infertility and women receiving fertility treatment experience a significantly higher risk of multiple indicators of severe maternal morbidity compared to fertile women. The increased risk of severe maternal morbidity noted among fertile black women compared to fertile white women is attenuated among infertile black women, who face risks similar to those of infertile white women.
引用
- Murugappan G, Li S, Lathi RB, et al. Increased risk of severe maternal morbidity among infertile women: analysis of US claims data. Am J Obstet Gynecol. 2020. PMID: 32112734. doi:10.1016/j.ajog.2020.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。